These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 33383560

  • 1. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.
    Wang H, Gao L, Qi M, Su P, Xiong X, Zhao J, Hu J, Han B.
    Biochem Biophys Res Commun; 2021 Jan 22; 537():22-28. PubMed ID: 33383560
    [Abstract] [Full Text] [Related]

  • 2. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J, Sun F, Chen W, Zhang J, Zhang T, Qi M, Feng T, Liu H, Li X, Xing Y, Xiong X, Shi B, Zhou G, Han B.
    J Exp Clin Cancer Res; 2019 May 28; 38(1):227. PubMed ID: 31138311
    [Abstract] [Full Text] [Related]

  • 3. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
    Zhou W, Yun Z, Wang T, Li C, Zhang J.
    Int J Biol Macromol; 2021 Sep 30; 187():800-810. PubMed ID: 34293363
    [Abstract] [Full Text] [Related]

  • 4. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.
    Li J, Zhang X, Liu X, Ma X, Wang Y, Liu Y.
    Expert Rev Anticancer Ther; 2024 Oct 30; 24(10):1029-1040. PubMed ID: 39254227
    [Abstract] [Full Text] [Related]

  • 5. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
    Hu J, Lai Y, Huang H, Ramakrishnan S, Pan Y, Ma VWS, Cheuk W, So GYK, He Q, Geoffrey Lau C, Zhang L, Cho WCS, Chan KM, Wang X, Rebecca Chin Y.
    Br J Cancer; 2022 Jan 30; 126(1):57-71. PubMed ID: 34718356
    [Abstract] [Full Text] [Related]

  • 6. Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling.
    Wang B, Ye Q, Zou C.
    Med Sci Monit; 2020 Jul 14; 26():e923507. PubMed ID: 32665537
    [Abstract] [Full Text] [Related]

  • 7. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L, Nuncia-Cantarero M, Morcillo-Garcia S, Nieto-Jimenez C, Burgos M, Corrales-Sanchez V, Perez-Peña J, Győrffy B, Ocaña A, Galán-Moya EM.
    Cell Oncol (Dordr); 2020 Jun 14; 43(3):431-444. PubMed ID: 32166583
    [Abstract] [Full Text] [Related]

  • 8. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL.
    Mol Cancer; 2019 Mar 18; 18(1):42. PubMed ID: 30885232
    [Abstract] [Full Text] [Related]

  • 9. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L.
    Cell Physiol Biochem; 2018 Mar 18; 48(5):1968-1982. PubMed ID: 30092563
    [Abstract] [Full Text] [Related]

  • 10. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F, Luo N, Hu Y, Li X, Zhang K.
    Cell Physiol Biochem; 2018 Mar 18; 47(5):2147-2158. PubMed ID: 29975921
    [Abstract] [Full Text] [Related]

  • 11. Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
    González-González A, Muñoz-Muela E, Marchal JA, Cara FE, Molina MP, Cruz-Lozano M, Jiménez G, Verma A, Ramírez A, Qian W, Chen W, Kozielski AJ, Elemento O, Martín-Salvago MD, Luque RJ, Rosa-Garrido C, Landeira D, Quintana-Romero M, Rosato RR, García MA, Ramirez-Tortosa CL, Kim H, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Lorente JA, Sánchez-Rovira P, Chang JC, Granados-Principal S.
    Clin Cancer Res; 2018 Nov 15; 24(22):5697-5709. PubMed ID: 30012564
    [Abstract] [Full Text] [Related]

  • 12. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
    Hata T, Rajabi H, Yamamoto M, Jin C, Ahmad R, Zhang Y, Kui L, Li W, Yasumizu Y, Hong D, Miyo M, Hiraki M, Maeda T, Suzuki Y, Takahashi H, Samur M, Kufe D.
    Mol Cancer Ther; 2019 Oct 15; 18(10):1744-1754. PubMed ID: 31308076
    [Abstract] [Full Text] [Related]

  • 13. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S, Vomhof-DeKrey E, Basson MD.
    Cell Physiol Biochem; 2019 Oct 15; 53(6):999-1014. PubMed ID: 31838790
    [Abstract] [Full Text] [Related]

  • 14. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.
    Guo Q, Qiu P, Pan K, Liang H, Liu Z, Lin J.
    Sci Rep; 2024 Sep 13; 14(1):21449. PubMed ID: 39271768
    [Abstract] [Full Text] [Related]

  • 15. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
    Doherty MR, Parvani JG, Tamagno I, Junk DJ, Bryson BL, Cheon HJ, Stark GR, Jackson MW.
    Breast Cancer Res; 2019 Apr 29; 21(1):54. PubMed ID: 31036052
    [Abstract] [Full Text] [Related]

  • 16. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer.
    Bai X, Ni J, Beretov J, Wang S, Dong X, Graham P, Li Y.
    Adv Sci (Weinh); 2021 Dec 29; 8(24):e2102658. PubMed ID: 34708581
    [Abstract] [Full Text] [Related]

  • 17. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S, Yu H, Zhou D, Fan X, Duan Y, Tan Y, Lang M, Shao G.
    J Transl Med; 2023 Oct 14; 21(1):721. PubMed ID: 37838657
    [Abstract] [Full Text] [Related]

  • 18. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.
    BMC Cancer; 2016 Nov 14; 16(1):887. PubMed ID: 27842518
    [Abstract] [Full Text] [Related]

  • 19. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 14; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 20. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
    De Santis F, Romero-Cordoba SL, Castagnoli L, Volpari T, Faraci S, Fucà G, Tagliabue E, De Braud F, Pupa SM, Di Nicola M.
    Cell Oncol (Dordr); 2022 Apr 14; 45(2):257-274. PubMed ID: 35357654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.